Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Revenue: 2024-2025

Historic Revenue for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $20.8 million.

  • Kura Oncology's Revenue rose 5136.41% to $20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 million, marking a year-over-year change of. This contributed to the annual value of $53.9 million for FY2024, which is 3578.57% up from last year.
  • Kura Oncology's Revenue amounted to $20.8 million in Q3 2025, which was up 35.73% from $15.3 million recorded in Q2 2025.
  • Kura Oncology's 5-year Revenue high stood at $20.8 million for Q3 2025, and its period low was -$412,000 during Q3 2024.
  • Moreover, its 2-year median value for Revenue was -$398,000 (2024), whereas its average is $6.9 million.
  • Data for Kura Oncology's Revenue shows a peak YoY surged of 5,136.41% (in 2025) over the last 5 years.
  • Over the past 2 years, Kura Oncology's Revenue (Quarterly) stood at -$403,000 in 2024, then skyrocketed by 5,136.41% to $20.8 million in 2025.
  • Its Revenue was $20.8 million in Q3 2025, compared to $15.3 million in Q2 2025 and $14.1 million in Q1 2025.